Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer

NCT03737695 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03737695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03737695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
September 16, 2019
Completion date
September 15, 2027
Enrollment
300 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, invasive breast carcinoma, metastatic breast carcinoma, peritoneal effusion, recurrent breast carcinoma